חן ורשנברוט
596 posts
I’ve been sitting on this one for a while — reading every filing, tracking every press release, talking to people who know the space. Today I’m sharing what I found in a 2 part artcile . $lib.v $vltvf @spideysignals/note/c-247500156?utm_source=notes-share-action&r=2c7dg1" target="_blank" rel="nofollow noopener">substack.com/@spideysignals…
I’ve been sitting on this one for a while — reading every filing, tracking every press release, talking to people who know the space. Today I’m sharing what I found in a 2 part artcile . $lib.v $vltvf @spideysignals/note/c-247500156?utm_source=notes-share-action&r=2c7dg1" target="_blank" rel="nofollow noopener">substack.com/@spideysignals…
$MDNAF $MDNA.to MDNA113's tumor-anchored, conditionally activated architecture addresses safety/dosing limitations that constrained 1st-gen molecules, enabling dosing comparable to approved anti-PD-1s without systemic toxicity. #Cancer #Biotech #Bispicific #NSCLC #Melanoma
$MDNAF $MDNA.to #AACR2026 Poster Presentation MDNA113 is a masked conditionally activated tumor-targeted anti-PD1-IL-2SK with superior safety and therapeutic properties ir.medicenna.com/static-files/7…
$MDNAF $MDNA.to GAME-CHANGING SAFETY PROFILE: Head-to-head NHP study vs anti-PD-1 x IL-2α-bispecific: • MDNA113: Well tolerated up to 50mg/kg, repeat dosing no treatment-limiting • Competitor (Takeda IBI363) 1.4 mg/kg: Severe vascular leak syndrome, could not receive 2nd dose
$MDNAF $MDNA.to MARKET VALIDATION: PD-1 x IL-2 bispecifics have validated multi-billion dollar commercial potential
$MDNAF $MDNA.to MDNA113's tumor-anchored, conditionally activated architecture addresses safety/dosing limitations that constrained 1st-gen molecules, enabling dosing comparable to approved anti-PD-1s without systemic toxicity. #Cancer #Biotech #Bispicific #NSCLC #Melanoma
$MDNA $MDNAF Presents Positive Data Demonstrating Superior Safety and Efficacy Potential of its First-in-Class anti-PD-1 x IL-2 Bifunctional Superkine MDNA113 at #AACR26 ir.medicenna.com/news-releases/…
$MDNAF $MDNA.to just rolled out a fresh, sleek& highly professional new website A well‑timed upgrade ahead of MDNA113 data release at #AACR26 & @BloomBurton conference-Toronto Smart move, presentation matters, especially going into a catalyst-heavy period medicenna.com
LibertyStream Commences Lithium Carbonate Production at Select Water Solutions Facility and Secures First U.S. Purchase Order $LIB.v $VLTLF businesswire.com/news/home/2026…
